MicroRNAs are endogenous small RNAs with a high degree of conservation, participating in a variety of vital activities. In present study, to explore the effect of microRNAs on 3T3-L1 adipocyte differentiation and adiponectin expression, the adipo-related microRNAs were screened and identified by micorRNA microarray. The highly expression plasmid of microRNA-21 with obvious expression up-regulation (miR-21) and its anti-sense (miR-21 inhibitor) were constructed and transfected into 3T3-L1 preadipocytes. The effect of miR-21 on 3T3-L1 adipocyte differentiation was observed, and the protein and mRNA expression level of adiponectin and AP-1 were analyzed. Results showed that, the expression profiles of microRNAs significantly changed during 3T3-L1 adipocyte differentiation. The expression of miR-21 was obviously up-regulated. miR-21 could significantly promote adipocyte differentiation, increase adiponectin mRNA and protein expression, while decrease AP-1 protein level. Meanwhil, miR-21 inhibitor blocked the effects of miR-21 mentioned above. The overexpression of AP-1 could absolutely reverse the stimulatory effect of miR-21 on adiponectin. miR-21 plays an important role in regulating adipocyte differentiation and adiponectin expression by inhibiting AP-1 expression.
机构:
Guangxi Med Univ, Affiliated Hosp 1, Dept Radiotherapy, Nanning 530021, Peoples R ChinaGuangxi Med Univ, Affiliated Hosp 1, Dept Radiotherapy, Nanning 530021, Peoples R China
Kang, Min
Yan, Li-Mei
论文数: 0引用数: 0
h-index: 0
机构:
Univ South China, Ctr Biochem, Hengyang 421001, Peoples R ChinaGuangxi Med Univ, Affiliated Hosp 1, Dept Radiotherapy, Nanning 530021, Peoples R China
Yan, Li-Mei
Zhang, Wen-Yu
论文数: 0引用数: 0
h-index: 0
机构:
Guangxi Med Univ, Coll Pharmacol, Nanning 530021, Peoples R ChinaGuangxi Med Univ, Affiliated Hosp 1, Dept Radiotherapy, Nanning 530021, Peoples R China
Zhang, Wen-Yu
Li, Yu-Mei
论文数: 0引用数: 0
h-index: 0
机构:
Guangxi Med Univ, Coll Pharmacol, Nanning 530021, Peoples R ChinaGuangxi Med Univ, Affiliated Hosp 1, Dept Radiotherapy, Nanning 530021, Peoples R China
Li, Yu-Mei
Tang, An-Zhou
论文数: 0引用数: 0
h-index: 0
机构:
Guangxi Med Univ, Affiliated Hosp 1, Dept Radiotherapy, Nanning 530021, Peoples R ChinaGuangxi Med Univ, Affiliated Hosp 1, Dept Radiotherapy, Nanning 530021, Peoples R China
Tang, An-Zhou
Ou, He-Sheng
论文数: 0引用数: 0
h-index: 0
机构:
Guangxi Med Univ, Coll Pharmacol, Nanning 530021, Peoples R ChinaGuangxi Med Univ, Affiliated Hosp 1, Dept Radiotherapy, Nanning 530021, Peoples R China
机构:
Univ S China, Inst Pharm & Pharmacol, Div Pharmacoprote, Hengyang, Peoples R ChinaUniv S China, Inst Pharm & Pharmacol, Div Pharmacoprote, Hengyang, Peoples R China
Ling, H. Y.
Ou, H. S.
论文数: 0引用数: 0
h-index: 0
机构:
Univ S China, Inst Pharm & Pharmacol, Div Pharmacoprote, Hengyang, Peoples R ChinaUniv S China, Inst Pharm & Pharmacol, Div Pharmacoprote, Hengyang, Peoples R China
Ou, H. S.
Lei, X. Y.
论文数: 0引用数: 0
h-index: 0
机构:
Univ S China, Inst Pharm & Pharmacol, Div Pharmacoprote, Hengyang, Peoples R ChinaUniv S China, Inst Pharm & Pharmacol, Div Pharmacoprote, Hengyang, Peoples R China
Lei, X. Y.
Zhu, B. Y.
论文数: 0引用数: 0
h-index: 0
机构:
Univ S China, Inst Pharm & Pharmacol, Div Pharmacoprote, Hengyang, Peoples R ChinaUniv S China, Inst Pharm & Pharmacol, Div Pharmacoprote, Hengyang, Peoples R China
Zhu, B. Y.
Yin, W. D.
论文数: 0引用数: 0
h-index: 0
机构:
Univ S China, Inst Pharm & Pharmacol, Div Pharmacoprote, Hengyang, Peoples R ChinaUniv S China, Inst Pharm & Pharmacol, Div Pharmacoprote, Hengyang, Peoples R China
Yin, W. D.
Liao, D. F.
论文数: 0引用数: 0
h-index: 0
机构:
Univ S China, Inst Pharm & Pharmacol, Div Pharmacoprote, Hengyang, Peoples R ChinaUniv S China, Inst Pharm & Pharmacol, Div Pharmacoprote, Hengyang, Peoples R China
Liao, D. F.
RECENT ADVANCES IN CARDIOVASCULAR DISEASE: PROCEEDINGS OF THE 13TH WORLD CONGRESS HEART DISEASE,
2007,
: 263
-
267
机构:
Agouron Pharmaceut Inc, Drug Safety Evaluat, Pfizer Global Res & Dev, San Diego, CA 92121 USAAgouron Pharmaceut Inc, Drug Safety Evaluat, Pfizer Global Res & Dev, San Diego, CA 92121 USA
Jessen, BA
Stevens, GJ
论文数: 0引用数: 0
h-index: 0
机构:
Agouron Pharmaceut Inc, Drug Safety Evaluat, Pfizer Global Res & Dev, San Diego, CA 92121 USAAgouron Pharmaceut Inc, Drug Safety Evaluat, Pfizer Global Res & Dev, San Diego, CA 92121 USA
机构:
Korea Univ, Grad Sch Med, Cellular Oncol Lab, Ansan 425707, Gyeonggi Do, South KoreaKorea Univ, Grad Sch Med, Cellular Oncol Lab, Ansan 425707, Gyeonggi Do, South Korea
Yoo, Wonbaek
Lee, Jaeseob
论文数: 0引用数: 0
h-index: 0
机构:
Korea Univ, Grad Sch Med, Cellular Oncol Lab, Ansan 425707, Gyeonggi Do, South KoreaKorea Univ, Grad Sch Med, Cellular Oncol Lab, Ansan 425707, Gyeonggi Do, South Korea
Lee, Jaeseob
Park, Sangeun
论文数: 0引用数: 0
h-index: 0
机构:
Korea Univ, Grad Sch Med, Cellular Oncol Lab, Ansan 425707, Gyeonggi Do, South KoreaKorea Univ, Grad Sch Med, Cellular Oncol Lab, Ansan 425707, Gyeonggi Do, South Korea
Park, Sangeun
Kim, Young-Sik
论文数: 0引用数: 0
h-index: 0
机构:
Korea Univ, Ansan Hosp, Dept Pathol, Ansan 425707, Gyeonggi Do, South KoreaKorea Univ, Grad Sch Med, Cellular Oncol Lab, Ansan 425707, Gyeonggi Do, South Korea
Kim, Young-Sik
Lim, Chaeseung
论文数: 0引用数: 0
h-index: 0
机构:
Korea Univ, Ansan Hosp, Dept Lab Med, Ansan 425707, Gyeonggi Do, South KoreaKorea Univ, Grad Sch Med, Cellular Oncol Lab, Ansan 425707, Gyeonggi Do, South Korea
Lim, Chaeseung
Yoon, Eulsik
论文数: 0引用数: 0
h-index: 0
机构:
Korea Univ, Ansan Hosp, Dept Plast & Reconstruct Surg, Ansan 425707, Gyeonggi Do, South KoreaKorea Univ, Grad Sch Med, Cellular Oncol Lab, Ansan 425707, Gyeonggi Do, South Korea
Yoon, Eulsik
Hur, Gangmin
论文数: 0引用数: 0
h-index: 0
机构:
Chungnam Natl Univ, Coll Med, Dept Pharmacol, Taejon 301131, South KoreaKorea Univ, Grad Sch Med, Cellular Oncol Lab, Ansan 425707, Gyeonggi Do, South Korea
Hur, Gangmin
Oh, Junseo
论文数: 0引用数: 0
h-index: 0
机构:
Korea Univ, Grad Sch Med, Cellular Oncol Lab, Ansan 425707, Gyeonggi Do, South KoreaKorea Univ, Grad Sch Med, Cellular Oncol Lab, Ansan 425707, Gyeonggi Do, South Korea